Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 13 of 15
Assessing Costs & Cost-variability Among Enrollees of Health Insurance Programs Utilizing Charlson's Comorbidity Index and Administrative Databases
NCT01761253
A Prospective Evaluation of the GreenLight Model 120 Laser
NCT00364585
Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma
NCT00901238
Ventricular Asynchrony in Cardiac Surgery Patients
NCT00654199
Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
NCT00320151
The Effect of the Patient Activation Measure on Chronic Care
NCT00299468
Problem Adaptation Therapy (PATH) vs. Supportive Therapy in Treating Depressed, Cognitively Impaired Older Adults
NCT00368940
Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium
NCT00324883
Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
NCT00288873
Intra Ocular Pressure During Robotic Prostatectomy
NCT00369057
Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
NCT00299988
Prospective Evaluation of Combined Laparoscopy With CO2 Intraoperative Colonoscopy Treatment for Colorectal Lesions
NCT00725465
Efficacy of Enteral Iron Supplementation in Critical Illness
NCT00450177
Exploring Folk Health Practices in Latinos With Chronic Medical Conditions
NCT00224237
Treatment of Bipolar Mania in Older Adults
NCT00254488
White Matter Fiber Tracking and Assessment of White Matter Integrity in the Cervical Spinal Cord
NCT00280306
Blood Collection From Individuals With Lung Disease for Genetic Studies
NCT00362739
Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy
NCT00662987
Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
NCT00926653
Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function
NCT00404950
High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration
NCT00277784
Use of Sucrose to Relieve Pain During Eye Exams in Infants
NCT00161694
Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma
NCT00148317
Use of Multiphoton Microscopy in the Diagnosis of Cancer
NCT00652210
Music's Effects on Premature Babies.
NCT00224211
Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
NCT00936845
Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection
NCT00195026
Quality of Life After Open Heart Surgery in Older Patients
NCT00248898
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
NCT00130286
Does Statin Initiation Undermine Dietary Behavior?
NCT00224159
Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
NCT00632632
Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
NCT00279669
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
NCT00151203
Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
NCT00151281
The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis
NCT00151294
A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients
NCT00248872
A Randomized Trial of Changing Exercise and Physical Activity Behavior in Asthma Patients
NCT00195117
A Randomized Trial: Changing Behavior in Post-Angioplasty Patients
NCT00248846
Safety Study of ORG 34517 for Major Depression With Psychotic Features
NCT00226278
Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease
NCT00248859
Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer
NCT00195039
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)
NCT00194922
An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)
NCT00194909
Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma
NCT00161590
Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis
NCT00151216
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
NCT00195078
Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I
NCT00277758
A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients
NCT00248937
A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients
NCT00248950
Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma Patients
NCT00227162
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.